Regulatory Terms Starting With O

Orange Book (Orange Book)

FDA's publication identifying drug products approved on the basis of safety and effectiveness with associated therapeutic equivalence evaluations.

Orphan Drug Designation (ODD)

A status granted to drugs intended to treat rare diseases affecting fewer than 200,000 people in the US.

Out of Specification (OOS)

A test result that falls outside the established acceptance criteria or specifications.